“雙重診斷雜志”是一份季刊，國際刊物，側重于雙重診斷的全部復雜性。精神健康和物質使用障礙或“雙重診斷”的共同發生是行為健康的典型問題之一。為什么存在如此高的共現率？它告訴我們有關風險概況的信息？這些相關疾病如何影響人們，他們的家庭以及他們所居住的社區？恢復的自然途徑是什么？哪些具體的治療方法最有幫助？如何開發新的治療方法？我們如何在臨床，行政和政策層面加強循證實踐的實施？我們如何幫助客戶學習主動康復技能并采用所需的支持，臨床醫生掌握新的干預措施，實施有效服務的計劃以及促進健康調整的社區？雙重診斷雜志包括來自與該領域相關的四個總體領域的文章和觀點：精神藥理學和神經生物學;心理治療與心理社會問題;服務與政策;和臨床論壇。每個問題都有助于鼓勵這些領域的整合。該雜志旨在發表與廣泛對雙重診斷感興趣的人相關的文章：研究人員，醫生，臨床醫生，受訓人員，管理人員和政策制定者。高質量的實證研究，簡要報告，及時評論，發人深思的評論以及對臨床問題的持續討論將被考慮出版，所有這些都旨在更好地理解共同基礎和最佳治療方法。發生精神和物質使用障礙。

Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment?Journal of Dual Diagnosis includes articles and perspectives from four overarching domains relevant to the field: Psychopharmacology & Neurobiology; Psychotherapy & Psychosocial Issues; Services & Policy; and Clinical Forum. Each issue serves to encourage integration of these domains. The Journal seeks to publish articles relevant to a wide range of people interested in dual diagnosis: researchers, physicians, clinicians, trainees, administrators, and policy makers. High-quality empirical research, brief reports, timely reviews, thought-provoking commentaries, and ongoing discussions of clinical issues will be considered for publication, all with the aim of developing a better understanding of the basis of, and optimal treatment for, co-occurring psychiatric and substance use disorders.